Revise the Inflation Reduction Act to Benefit Senior Health

The Popularity of Medicare Part D

With over 50 million individuals enrolled, Medicare Part D has become a widely popular voluntary health benefit for America’s seniors. Despite its longstanding success, recent structural changes brought about by the 2022 Inflation Reduction Act (IRA) are posing a threat to the program’s effectiveness.

Rising Premiums and Decreasing Plan Options

Since the IRA’s enactment, Part D premiums have surged, with average increases of 21% this year and projections to double by 2025. For seniors on fixed incomes, these rising costs can have significant negative impacts on their financial well-being. Additionally, the number of available Medicare prescription drug plans has drastically decreased from 1,429 plans in 2006 to just 709 plans in 2024, with a further decrease of 92 plans in the past year alone. This reduction in plan options can limit seniors’ access to necessary medications and treatments.

Concerns for Seniors’ Health Care

As seniors age, the need for prompt and effective medical treatment becomes crucial. The IRA’s impact on Part D plans could lead to fragmented care options and limited coverage for high-quality medications. This could result in poorer health outcomes for seniors who rely on these plans for managing their health conditions.

A Call to Action

The changes brought about by the IRA are creating obstacles for America’s aging population to access essential health care services. It is imperative for Congress to address these challenges and ensure that seniors receive the medication and coverage they need to maintain their well-being.

Mark Gibbons is the President and CEO of RetireSafe, an organization dedicated to advocating for the rights and well-being of seniors. With a background in military service and senior advocacy, Gibbons brings a wealth of experience to the fight for improved health care access for aging Americans.